Market Closed

FTH
Faeth Therapeutics
$ 10.03
-5.82%   Last 24H
 
Trading with leverage comes with a high risk and may not be suitable for everyone.
   
Trading with leverage comes with a high risk and may not be suitable for everyone.
Portfolio
Updated a day ago

Faeth Therapeutics News

Latest Faeth Therapeutics Stock News & FTH Headlines

Faeth Therapeutics to Participate in Upcoming November Investor Conferences
4 days ago | businesswire.com
Faeth Therapeutics Reports Third Quarter 2026 Financial Results and Operational Updates
12 days ago | businesswire.com
Faeth Presents Updated Preclinical Data at ESMO, including First-Ever Head-to-Head Characterization of PIKTOR against Gedatolisib
23 days ago | businesswire.com
Faeth to Present Preclinical Data on PIKTOR in HR+/HER2- Breast Cancer Models at ESMO 2026
a month ago | businesswire.com
Sensei Biotherapeutics (NASDAQ:FTH) Shares Gap Up – Here’s What Happened
a month ago | defenseworld.net
Faeth Therapeutics Appoints Karen Vousden, Ph.D., to Board of Directors
2 months ago | gurufocus.com
Faeth Therapeutics Appoints Karen Vousden, Ph.D., to Board of Directors
2 months ago | businesswire.com
What Makes Faeth Therapeutics, Inc. (FTH) a Strong Momentum Stock: Buy Now?
2 months ago | zacks.com
Faeth Therapeutics to Participate in Upcoming September Investor Conferences
2 months ago | gurufocus.com
Faeth Therapeutics to Participate in Upcoming September Investor Conferences
2 months ago | businesswire.com
Load More

Download App

Keep track of your holdings and explore over 40,000 cryptocurrencies

oinCodex Android App
CoinCodex Mobile App
Market Closed

FTH
Faeth Therapeutics
$ 10.03
-5.82%   Last 24H
 
Trading with leverage comes with a high risk and may not be suitable for everyone.
   
Trading with leverage comes with a high risk and may not be suitable for everyone.
Portfolio
Updated a day ago